Natali_Mis/iStock via Getty Images
ANGLE plc (OTCQX:ANPCF) and Myriad Genetics (NASDAQ:MYGN) have announced a new partnership to advance cancer diagnostics.
The collaboration will use ANGLE’s Parsortix® system to capture cancer cells from patient blood samples. The captured cancer cells will then be compared to patient tissue samples
